RCEL - Avita Medical Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCEL is currently covered by 4 analysts with an average price target of $11.17. This is a potential downside of $2.63 (-19.06%) from yesterday's end of day stock price of $13.8.

Avita Medical Ltd's activity chart (see below) currently has 79 price targets and 75 ratings on display. The stock rating distribution of RCEL is 73.33% BUY, 6.67% SELL and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.76% with an average time for these price targets to be met of 109.13 days.

Highest price target for RCEL is $15, Lowest price target is $6, average price target is $11.17.

Most recent stock forecast was given by RYAN ZIMMERMAN from BTIG on 12-Oct-2026. First documented stock forecast 30-Dec-2019.

Currently out of the existing stock ratings of RCEL, 11 are a BUY (73.33%), 1 are a SELL (6.67%), 3 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Aug-2026

$15

$1.96 (15.03%)

$11

9 days ago
(12-Oct-2026)

3/7 (42.86%)

$1.79 (13.55%)

153

Buy Since 28-Aug-2026

$12

$-1.04 (-7.98%)

$6

1 months 23 days ago
(28-Aug-2026)

3/4 (75%)

$1.65 (15.94%)

41

Buy Since 21-Dec-2022

$14

$0.96 (7.36%)

$15

2 months 2 days ago
(19-Aug-2026)

1/4 (25%)

$3.66 (35.40%)

203

Buy Since 24-Dec-2024

$10

$6.03 (151.89%)

$10

6 months 11 days ago
(09-Apr-2026)

0/18 (0%)

$5.46 (120.26%)

Buy Since 27-Jun-2023

$11

$-2.04 (-15.64%)

$19

1 years 29 days ago
(22-Sep-2025)

1/15 (6.67%)

$5.08 (85.81%)

347

Show more analysts

Please expand the browser size to see the chart

What is RCEL (Avita Medical Ltd) average time for price targets to be met?

On average it took 109 days for the stock forecasts to be reached, with an average price target met ratio of 20.76%.

Which analyst most recently updated their price target on RCEL (Avita Medical Ltd)?

Ryan Zimmerman

Which analyst has the most public recommendations on RCEL (Avita Medical Ltd)?

Ryan Zimmerman works at BTIG and has 34 price targets and 25 ratings on RCEL

Which analyst is the currently most bullish on RCEL (Avita Medical Ltd)?

Lyanne Harrison with the highest potential upside of $17.03

Which analyst is the currently most reserved on RCEL (Avita Medical Ltd)?

Brooks O'neil with the lowest potential downside of -$5.04
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?